Cell Culture Technology– category –
-
Big Data and Predictive Analytics Revolutionize Bioreactor Performance, Enhancing Robustness, Efficiency, and Decision-Making
Facebook (Infors HT) Switzerland Overview The application of big data and predictive analytics to bioreactors is highlighted as maximizing potential by enhancing process robustness, efficiency, and decision-making. Utilizing real-time da... -
Australia’s VVMF Sydney Facility Secures TGA GMP License for Gene and Cell Therapy Manufacturing, Bolstering Domestic CDMO Capacity
Contract Pharma USA Overview Australia's Viral Vector Manufacturing Facility (VVMF) has officially received a Therapeutic Goods Administration (TGA) GMP license for therapeutic product manufacturing at its Sydney site, effective Septembe... -
Equipment-Level Digital Twins Deliver Real-Time Predictive Control and Anomaly Detection for Bioprocess Operations
BioProcess International USA Overview Equipment-level bioprocess digital twins, integrated with stirred-tank and perfusion bioreactors, now generate real-time predictive endpoints, deviation alerts, and recommended operating windows. Thi... -
Drug Discovery News Highlights Rising Complexity in Biologics Manufacturing: Urges Manufacturability by Design, Raw Material Quality, and Process Intensification
Drug Discovery News USA Overview Drug Discovery News reports on the increasing complexity in manufacturing biologics, cell-based therapies (including CAR T), viral vectors, and oligonucleotides. The article identifies key challenges such... -
iPSC Therapies: Manufacturing Consistency Requires Preserving Cell Functionality Beyond Basic Properties, Integrating Cell Line Selection and Genetic Engineering
Pharma's Almanac USA Overview An article in Pharma's Almanac highlights that iPSC-derived cardiomyocyte products, even with similar identity and purity, can exhibit differing functional performance, emphasizing the critical need to chara... -
BubbleGen: Bracco Imaging’s Bead-Free Microbubble Technology Revolutionizes CAR-T Cell Selection
Manufacturing Chemist Italy Overview Bracco Imaging has launched its BubbleGen CD3+ T Cell Selection Kit, a pioneering bead-free technology set to transform CAR-T cell manufacturing. Leveraging gas-core, lipid-shell microbubbles for gent... -
Amsbio Launches StemFit Basic04CT: Animal-Origin-Free iPSC Culture Medium Enables One-Step Media Switch, Streamlining Clinical Manufacturing
Lab Manager International Overview Amsbio has released performance data for StemFit Basic04CT, an animal-origin-free, chemically defined medium for human pluripotent stem cell (hPSC) culture, enabling a one-step media switch. This GMP-qu... -
Max Delbrück Center Research Reveals ‘Quality Over Quantity’ in CAR-T Therapy, Identifying Key Factors for Low-Dose Efficacy to Enable Personalized Treatment and Cost Reduction
Max Delbrück Center for Molecular Medicine Germany Overview A research consortium from the Max Delbrück Center, publishing in "Nature Communications," identified key biological factors influencing CAR-T cell therapy effectiveness at lowe... -
UCLA Scientists Mass-Produce Ready-to-Use Cord Blood-Derived T Cells for Solid Tumors in 6 Weeks at $5,000/Dose, Avoiding GvHD Risk
UCLA USA Overview UCLA researchers have developed a platform to mass-produce cancer-fighting T cells from cord blood stem cells, engineered to target solid tumors. This innovative approach generates trillions of therapeutic cells (thousa... -
SCG Cell Therapy Opens Automated Global Manufacturing & R&D Center in Singapore, Targeting 80% Cleanroom Reduction, 10x Production Capacity, and 70% Cost Cuts
Insight, China's Pharmaceutical Industry Singapore Overview SCG Cell Therapy has launched its global manufacturing and R&D center in Singapore, featuring a first-in-class, closed-off automated cell therapy production system. This cut...
